Hymon® Respiratory Triplex Panel Test Kit

Short Description:

Hymon^® Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.

Send email to us

Product Detail

Product Tags

Technical Advantages

• Rapid detection

Simultaneous detection of all three pathogens completed with an innovative and exclusive one-step method. RNA processing completed in 3 minutes, with sample-to-results in 35 minutes.

• One-tube multiplex testing

A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses.

• Accurate and safe

Full coverage of genes, multiplex detection, and multiple guarantees, among which the SARS-CoV-2 test has been approved by the FDA.

• Multiple monitoring

Operation quality control includes three internal standards: positive control, negative control, and human DNA gene sequence.

• Unique technology

Nanobody molecular locking technology (MoLock) improves sensitivity and specificity.

• High sensitivity

Sensitivity reaches 5 copies/reaction.

• CE Certification

Clinical Application

The Respiratory Triplex Panel Test Kit for COVID-19 and influenza A/B detects multiple pathogens in one tube, accurately distinguishes COVID-19 from HBV viruses, assists doctors in diagnosing disease, and provide a reliable basis for epidemic prevention and control and clinical treatment.

Previous: Hymon® COVID-19 Antigen Rapid Test Kit

Next: Hymon® MULTONE™ Urogenital Panel Test Kit

Write your message here and send it to us